 0 Table of Contents |
  1 Home |
  2 Regulatory Data |
  3 Clinical Data |
  4 Known Issues |
  5 Visualiser |
  6 Testing Tool Box |
  7 Artifacts Summary |
   7.1 Medicinal Product Logical Model |
   7.2 PPL Administrable Product profile |
   7.3 PPL Ingredient profile |
   7.4 PPL Manufactured Item profile |
   7.5 PPL Marketing Authorisation profile |
   7.6 PPL Medicinal Product profile |
   7.7 PPL Organization |
   7.8 PPL Packaged Product profile |
   7.9 Processing Profile - Administrable Product |
   7.10 Processing Profile - Ingredient |
   7.11 Processing Profile - Manufactured Item |
   7.12 Processing Profile - Marketing Authorisation |
   7.13 Processing Profile - Medicinal Product |
   7.14 Processing Profile - Organization |
   7.15 Processing Profile - Packaged Product |
   7.16 Equivalent Look Up |
   7.17 country |
   7.18 manufactured-item-packaging-ppd |
   7.19 manufactured-item-ppd |
   7.20 name-language-correct |
   7.21 reference-strength-substance |
   7.22 strength-presentation-quantity |
   7.23 strength-presentation-ratio |
   7.24 strength-presentation-ratio-denominator |
   7.25 strength-presentation-ratio-numerator |
   7.26 strength-quantity-and-substance |
   7.27 strength-ratio-and-substance |
   7.28 DRAFT: Medicinal Product in crossborder eP/eD |
   7.29 DRAFT: MyHealth@EU medicinal product |
   7.30 Medication for clinical workflows |
   7.31 SNOMED CT Clinical Drug |
   7.32 Medication |
   7.33 Medication as manufactured item |
   7.34 AD |
   7.35 ANY |
   7.36 BL |
   7.37 CD |
   7.38 Class |
   7.39 DT |
   7.40 EN |
   7.41 II |
   7.42 INT |
   7.43 PQ |
   7.44 REAL |
   7.45 RTO |
   7.46 ST |
   7.47 TS |
   7.48 Untyped |
   7.49 AdministrableDoseForm |
   7.50 MedicinalProductClassification |
   7.51 MedicinalProductName |
   7.52 Country (ISO 3166-1-2) |
   7.53 EDQM Administration Device |
   7.54 EDQM Administration Method |
   7.55 EDQM Basic Dose Form |
   7.56 EDQM Closure |
   7.57 EDQM Combination Pack |
   7.58 EDQM Combined Pharmaceutical Dose Form |
   7.59 EDQM Combined Term |
   7.60 EDQM Container |
   7.61 EDQM Intended Site |
   7.62 EDQM Packaging Category |
   7.63 EDQM Patient-friendly Term |
   7.64 EDQM Pharmaceutical Dose Form |
   7.65 EDQM Route of Administration |
   7.66 EDQM Unit of Presentation |
   7.67 EMA SPOR All Units Combined |
   7.68 EMA SPOR ATC |
   7.69 EMA SPOR Authorised Dose Form |
   7.70 EMA SPOR Country |
   7.71 EMA SPOR Domain |
   7.72 EMA SPOR Language |
   7.73 EMA SPOR Legal Status for the Supply |
   7.74 EMA SPOR Marketing Status |
   7.75 EMA SPOR Material |
   7.76 EMA SPOR Packaging |
   7.77 EMA SPOR Pharmaceutical Dose Form |
   7.78 EMA SPOR Record Status |
   7.79 EMA SPOR Regulatory Entitlement Status |
   7.80 EMA SPOR Routes and Methods of Administration |
   7.81 EMA SPOR Shelf Life Type |
   7.82 EMA SPOR SMS Substances |
   7.83 EMA SPOR Unit of Measurement |
   7.84 EMA SPOR Unit of Presentation |
   7.85 Language (FHIR) |
   7.86 MyHealth@EU Unit of Measurement (UCUM) |
   7.87 WHO ATC |
   7.88 ATC Human EMA |
   7.89 Combination Package EMA |
   7.90 Combined Pharmaceutical Dose Form EMA |
   7.91 Combined Term EMA |
   7.92 Country EMA |
   7.93 Domain EMA |
   7.94 Language EMA |
   7.95 Legal Status for the Supply EMA |
   7.96 Marketing Status EMA |
   7.97 Material EMA |
   7.98 Packaging EMA SPOR |
   7.99 Pharmaceutical Dose Form EMA |
   7.100 Record Status EMA SPOR |
   7.101 Regulatory Entitlement Status EMA SPOR |
   7.102 Routes and Methods of Administration EMA |
   7.103 Substances EMA SPOR SMS |
   7.104 Unit of Measurement EMA |
   7.105 Unit of Presentation EMA |
   7.106 EDQM-SPOR Pharmaceutical dose forms |
   7.107 SMS-SNOMED CT substances |
   7.108 001-Agen5mg-EE-FullProduct |
   7.109 002-Agen10mg-EE-FullProduct |
   7.110 003-CefuroximStragen-1-5g-Powder-SE-FullProduct |
   7.111 004-Cefuroxime-MIP-1500mg-EE-FullProduct |
   7.112 005-CanifugCremolum-EE-FullProduct |
   7.113 006-Yaz-002mg3mg-tablet-SE-FullProduct |
   7.114 007-Jangee-002mg-3mg-Film-coated-tablet-EE-FullProduct |
   7.115 008-Jangee-003mg-3mg-Film-coated-tablet-EE-FullProduct |
   7.116 009-Paracetamol-Kabi10mg-1ml-EE-FullProduct |
   7.117 010-Clexane-60mg-06ml-EE-FullProduct |
   7.118 011-Betaklav500-125-EE-FullProduct |
   7.119 012-Panodil-500mg-SolutionInSachet-SE-FullProduct |
   7.120 013-LantusSolostar-EE-FullProduct |
   7.121 014-CanestenKombi-FI-FullProduct |
   7.122 015-CopaliaHCT-EE-FullProduct |
   7.123 016-Lodipin-10mg-Capsule-GR-FullProduct |
   7.124 017-ImovaxPolio-EE-FullProduct |
   7.125 Agen-5mg-Tablet-EE-APD |
   7.126 Agen-5mg-Tablet-EE-I |
   7.127 Agen-5mg-Tablet-EE-MID |
   7.128 Agen-5mg-Tablet-EE-MPD |
   7.129 Agen-5mg-Tablet-EE-PPD-1109887-A |
   7.130 Agen-5mg-Tablet-EE-PPD-1109887-B |
   7.131 Agen-5mg-Tablet-EE-RA |
   7.132 AMLaccord-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.133 AMLaccord-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.134 AMLaurobindo-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.135 AMLbluefish-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.136 AMLbluefish-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.137 AMLHipres-10mg-Tablet-EE-FullProduct |
   7.138 AMLHipres-5mg-Tablet-EE-FullProduct |
   7.139 AMLjubilant-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.140 AMLjubilant-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.141 AMLkrka-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.142 AMLkrka-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.143 AMLmedvalley-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.144 AMLmedvalley-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.145 Amlodistad-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.146 Amlodistad-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.147 AMLsandoz-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.148 AMLsandoz-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.149 AMLteva-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.150 AMLteva-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.151 AMLvitabalans-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.152 AMLvitabalans-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.153 AT-Curocef-1500-Powder |
   7.154 CanifugCremolum-100mg-Pessary-EE-APD |
   7.155 CanifugCremolum-100mg-Pessary-EE-I |
   7.156 CanifugCremolum-100mg-Pessary-EE-MID |
   7.157 CanifugCremolum-10mg1g-Cream-EE-APD |
   7.158 CanifugCremolum-10mg1g-Cream-EE-I |
   7.159 CanifugCremolum-10mg1g-Cream-EE-MID |
   7.160 CanifugCremolum-EE-Cream-Medication-Item |
   7.161 CanifugCremolum-EE-Medication-Clinical |
   7.162 CanifugCremolum-EE-MPD |
   7.163 CanifugCremolum-EE-Pessary-Medication-Item |
   7.164 CanifugCremolum-EE-PPD-1033692 |
   7.165 CanifugCremolum-EE-RA |
   7.166 Cefuroxime-MIP-1500mg-EE-APD |
   7.167 Cefuroxime-MIP-1500mg-EE-I |
   7.168 Cefuroxime-MIP-1500mg-EE-MID |
   7.169 Cefuroxime-MIP-1500mg-EE-MPD |
   7.170 Cefuroxime-MIP-1500mg-EE-PPD-1529940 |
   7.171 Cefuroxime-MIP-1500mg-EE-PPD-1529962 |
   7.172 Cefuroxime-MIP-1500mg-EE-RA |
   7.173 Cefuroxime1500-Medication-Clinical |
   7.174 Cefuroxime1500-Powder-Medication-Item |
   7.175 CefuroximeMIP-EE-Medication-Clinical |
   7.176 CefuroximeMIP-EE-Powder-Medication-Item |
   7.177 Clotrimazole-cream-and-pessaries-Medication-Clinical |
   7.178 Clotrimazole-Cream-Generic |
   7.179 LOC-100000551-KrkaSverige |
   7.180 LOC-100002580-Zentiva |
   7.181 LOC-100004795-Wolff-Arzneimittel |
   7.182 LOC-100009199-Mip |
   7.183 Norvasc-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
   7.184 Norvasc-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |